explore -WSS

explore

author：focus 2025-09-30 02:15:43 - browse：59

Miniature people figurines standing in a group looking down. -- health tech coverage from STAT — Adobe

In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud.

Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt. Twelve companies have lost more than 90% of their initial value, including Bright Health Group, Cue Health, and Better Therapeutics. And dangerously low reserves have inspired desperate moves to slash costs, drum up liquidity, and find buyers.

Most recently, the bankruptcy of digital primary care company Babylon Health has drawn attention to the plight of newly-public health tech companies, and how the froth of dealmaking at the height of the pandemic led to overblown valuations. Before its debut in June 2021, Babylon was valued at $4.2 billion; after filing for bankruptcy in August, its U.K. telemedicine business was sold for just over $600,000.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Vertex cell therapy lets patients with type 1 diabetes stop insulin

entertainment

WSS

Cancer diagnosis changes perspective doctor, former hospital CEO

Prescription digital therapeutics are key to pharma’s future

Use doctors trained outside the U.S. to ease the physician shortage

Ventyx halts psoriasis drug development after lackluster trial results

Type 2 diabetes prevention programs work at large scale: study

How state and local governments are sidelining science

Wikipedia

explore

focus

Wildfire smoke exposes gaps in outdoor worker protections

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Activists slam private health insurers over coverage restrictions

Medicare’s new pay boost for primary care is angering specialists

The cancer drug shortage isn’t new — and neither are the solutions

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Affirmative action in medical school literally saved lives

Lupron, used to halt puberty in children, may cause lasting health problems

hotspot

Healthy food access boosts outcomes in two studies

Crowdfunding for unproven stem cell procedures spreads misinformation

Healthy food access boosts outcomes in two studies

FDA reorg will put new emphasis on investigations, sources say

'Screen and refer' systems are hurting patients

Drug cartel violence flares in western Mexico after vigilante leader's killing

knowledge

entertainment

hotspot

leisure time